MOA Life Plus Co. Ltd.

KOSDAQ:A142760 Stock Report

Market Cap: ₩14.7b

MOA Life Plus Past Earnings Performance

Past criteria checks 0/6

MOA Life Plus has been growing earnings at an average annual rate of 16.7%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been declining at an average rate of 48.7% per year.

Key information

16.67%

Earnings growth rate

28.12%

EPS growth rate

Biotechs Industry Growth11.70%
Revenue growth rate-48.66%
Return on equity-39.98%
Net Margin-122.17%
Last Earnings Update31 Mar 2026

Recent past performance updates

No updates

Recent updates

Analysis Article • Jan 22

Is MOA Life Plus (KOSDAQ:142760) Using Debt In A Risky Way?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Oct 01

Is MOA Life Plus (KOSDAQ:142760) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jun 10

MOA Life Plus Co. Ltd.'s (KOSDAQ:142760) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

MOA Life Plus Co. Ltd. ( KOSDAQ:142760 ) shareholders have had their patience rewarded with a 26% share price jump in...
Analysis Article • Feb 06

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Oct 18

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Apr 19

There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Bioleaders Corporation ( KOSDAQ:142760 ) shares have continued their recent momentum with a 30% gain in the last month...
Analysis Article • Mar 01

Bioleaders Corporation's (KOSDAQ:142760) Business And Shares Still Trailing The Industry

You may think that with a price-to-sales (or "P/S") ratio of 0.5x Bioleaders Corporation ( KOSDAQ:142760 ) is...
Analysis Article • Feb 16

Bioleaders' (KOSDAQ:142760) Shareholders Are Down 47% On Their Shares

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Revenue & Expenses Breakdown

How MOA Life Plus makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A142760 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2610,452-12,7697,718941
31 Dec 2511,216-13,0317,579799
30 Sep 259,800-11,9297,701692
30 Jun 2512,160-12,8697,541419
31 Mar 2513,787-4,9347,145414
31 Dec 2415,630-6,9948,375579
30 Sep 2417,080-11,2835,982708
30 Jun 2418,436-12,0167,431950
31 Mar 2418,548-8,9228,2851,293
31 Dec 2318,245-6,2048,2251,501
30 Sep 23-40,63610,742-6,0441,915
30 Jun 23-16,1109,543-9063,100
31 Mar 231,909-2054,8643,451
31 Dec 2222,004-2,46811,4703,856
30 Sep 22104,738-26,14834,1084,567
30 Jun 2299,393-21,28435,1204,007
31 Mar 22100,298-19,15934,3304,409
31 Dec 21101,170-19,76831,3894,481
30 Sep 2198,814-15,68828,7133,781
30 Jun 2192,955-23,18426,2844,133
31 Mar 2185,999-21,77825,5653,673
31 Dec 2080,453-21,13826,9113,419
30 Sep 2067,761-24,86233,1673,388
30 Jun 2066,300-22,32433,5332,996
31 Mar 2067,138-27,90034,2432,783
31 Dec 1972,877-28,04635,8412,645
30 Sep 1987,455-24,52529,6562,817
30 Jun 1998,845-23,28633,5592,464
31 Mar 19107,313-17,11135,7972,555
31 Dec 1886,067-17,22829,2522,552
30 Sep 1862,205-9,13722,2862,504
30 Jun 1834,764-8,11112,8712,670
31 Mar 1811,497-7,8295,0452,707
31 Dec 177,607-6,6474,2672,739
31 Dec 162,501-5,8963,4382,820

Quality Earnings: A142760 is currently unprofitable.

Growing Profit Margin: A142760 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A142760 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.7% per year.

Accelerating Growth: Unable to compare A142760's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A142760 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (4.9%).

Return on Equity

High ROE: A142760 has a negative Return on Equity (-39.98%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/21 09:02
End of Day Share Price 2026/08/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MOA Life Plus Co. Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.